Fig. 1From: Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based studyCOM-B, derived from the Behaviour Change Wheel [45], TDF [40], and IMAB [25]Back to article page